Necrotizing Enterocolitis Market: Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight
Necrotizing Enterocolitis (NEC) is an inflammatory disease of intestine largely occurring in preterm infants with a wide range of damage from minimal injury limited to mucosa to extensive necrosis of bowel wall and perforation. It is the most common neonatal gastrointestinal emergency, particularly in those born at, 32 weeks’ gestation and/or, 1,500 g birth weight. The exact cause of NEC isn’t known. However, it’s believed that a lack of oxygen during a difficult delivery may be a contributing factor. When there’s reduced oxygen or blood flow to the intestine, it can become weak. A weakened state makes it easier for bacteria from the food entering the intestine to cause damage to the intestinal tissues. This can lead to the development of an infection or NEC.
DelveInsight's "Necrotizing
Enterocolitis Market Insights, Epidemiology, and Market Forecast-2030" report
delivers an in-depth understanding of the Necrotizing Enterocolitis, historical
and forecasted epidemiology as well as the Necrotizing Enterocolitis market
trends in the United States, EU5 (Germany, Spain, Italy, France, and United
Kingdom) and Japan.
Some facts of Necrotizing
Enterocolitis Market Report are:
·
As per Robert C. Holman et al, NEC occurs in
approximately 10% of VLBW infants and is associated with 1.0–7.5% of all
neonatal intensive care unit admissions. Also, found that approximately 4500
neonates (or approximately 1 infant per 1000 live births) are hospitalized each
year in the United States
·
According to Simon Eaton UK NEC study, estimates
based on over 100,000 infants, of whom more than 500 had severe NEC, with an
incidence of around 3% in infants <32 weeks gestational age
·
According to Clare M. Rees et Al, Bell's stage I
was the most frequent maximum stage of NEC diagnosed with 45%, stage II at 18%
to 24% and stage III at 30% to 37% in the United Kingdom
·
According to Katherine E. Gregory et al, the
majority of NEC cases are treated medically, and more than one-fourth of
infants will require urgent surgical intervention including exploratory
laparotomy, bowel resection, and ostomy
View Report: https://www.delveinsight.com/report-store/necrotizing-enterocolitis-market
Request for Sample
Report: https://www.delveinsight.com/sample-request/necrotizing-enterocolitis-market
Scope of Necrotizing
Enterocolitis Market Report are:
- The
report covers the descriptive overview of Necrotizing Enterocolitis,
explaining its causes, signs and symptoms, pathophysiology, diagnosis and
currently available therapies
- Comprehensive
insight has been provided into the Necrotizing Enterocolitis epidemiology
and treatment in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for Necrotizing
Enterocolitis are provided, along with the assessment of new therapies,
which will have an impact on the current treatment landscape
- A
detailed review of Necrotizing Enterocolitis market; historical and
forecasted is included in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Necrotizing
Enterocolitis market
View Report: https://www.delveinsight.com/report-store/necrotizing-enterocolitis-market
Some of Necrotizing
Enterocolitis Companies are:
·
Infant Bacterial Therapeutics
·
Leadiant Biosciences
·
Noveome Biotherapeutics
·
Prometic Life Sciences
·
And Many Others
Request for Sample
Report: https://www.delveinsight.com/sample-request/necrotizing-enterocolitis-market
Necrotizing
Enterocolitis Therapies are:
·
IBP-9414
·
STP206
·
Inter-Alpha-Inhibitor-Proteins
·
And Many Others
View Report: https://www.delveinsight.com/report-store/necrotizing-enterocolitis-market
Table of Contents:
1. Key Insights
2. Executive Summary
of Necrotizing Enterocolitis
3. Competitive
Intelligence Analysis for Necrotizing Enterocolitis
4. Necrotizing
Enterocolitis: Market Overview at a Glance
4.1. Necrotizing Enterocolitis Total Market Share (%)
Distribution in 2018
4.2. Necrotizing Enterocolitis Total Market Share (%)
Distribution in 2030
5. Necrotizing
Enterocolitis: Disease Background and Overview
6. Patient Journey
7. Necrotizing
Enterocolitis Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
8.1. Necrotizing Enterocolitis Treatment and Management
8.2. Necrotizing Enterocolitis Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of
Necrotizing Enterocolitis Treatment
11. Marketed
Products
List to be continued
in report
12. Emerging
Therapies
List to be continued
in report
13. Necrotizing
Enterocolitis: Seven Major Market Analysis
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and
Reimbursement Overview of Necrotizing Enterocolitis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
Some of Newly Launched Report:
·
Neuromodulation
Devices market
·
Neurostimulation
Devices market
·
Hernia
repair devices market
About Delveinsight:
DelveInsight Business Research is a leading Market
Research, and Business Consultant focused purely on Healthcare. It
helps pharma companies by providing them with end-to-end services to solve
their business problems.
Get hold of all the Pharma and healthcare market research
reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business
Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment